• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

280.31 +7.40 (+2.71%)
Streaming Delayed Price Updated: 3:26 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 130,649
Open 273.03
Bid (Size) 279.77 (300)
Ask (Size) 280.73 (100)
Prev. Close 272.91
Today's Range 273.03 - 283.61
52wk Range 122.80 - 295.98
Shares Outstanding 22,205,642
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
January 25, 2026
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
January 24, 2026
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool

Performance

YTD
+13.5%
+13.5%
1 Month
+10.5%
+10.5%
3 Month
+51.5%
+51.5%
6 Month
+82.9%
+82.9%
1 Year
+76.1%
+76.1%

More News

Read More
News headline image
Why a Fund Placed a $13 Million Bet on Ambarella Stock Before a 20% Post-Earnings Drop ↗
December 19, 2025
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Via Benzinga
News headline image
Is IPG Photonics Stock a Buy as One Fund Builds a $9 Million Stake in the Firm? ↗
December 19, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund Has an $8.5 Million Bet on Five9 Despite a 50% One-Year Stock Collapse ↗
December 19, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
December 03, 2025
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
December 03, 2025
Via The Motley Fool
News headline image
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
December 03, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today ↗
November 12, 2025
Via Benzinga
News headline image
Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
November 10, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
What's Driving the Market Sentiment Around Krystal Biotech Inc? ↗
November 06, 2025
Via Benzinga
News headline image
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript ↗
November 03, 2025
Via The Motley Fool
Topics Earnings
News headline image
Krystal Biotech (KRYS) Q3 2025 Earnings Top Estimates on Strong VYJUVEK Sales ↗
November 03, 2025
Via Chartmill
News headline image
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today ↗
October 31, 2025
Via Benzinga
News headline image
Expert Outlook: Krystal Biotech Through The Eyes Of 9 Analysts ↗
October 17, 2025
Via Benzinga
News headline image
$100 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today ↗
October 16, 2025
Via Benzinga
News headline image
Insider Confidence Shines: Krystal Biotech and Growth Stocks with Strong Management Stakes Navigate Volatile Markets
October 15, 2025
Via MarketMinute
Topics Artificial Intelligence World Trade
News headline image
What's Driving the Market Sentiment Around Krystal Biotech Inc? ↗
October 10, 2025
Via Benzinga
News headline image
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner ↗
September 30, 2025
Via Benzinga
News headline image
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today ↗
September 25, 2025
Via Benzinga
News headline image
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today ↗
September 18, 2025
Via Benzinga
News headline image
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin ↗
September 15, 2025
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today ↗
September 02, 2025
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts ↗
August 22, 2025
Via Benzinga

Frequently Asked Questions

Is Krystal Biotech, Inc. - Common Stock publicly traded?
Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.
What exchange does Krystal Biotech, Inc. - Common Stock trade on?
Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?
The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market
What is the current price of Krystal Biotech, Inc. - Common Stock?
The current price of Krystal Biotech, Inc. - Common Stock is 280.31
When was Krystal Biotech, Inc. - Common Stock last traded?
The last trade of Krystal Biotech, Inc. - Common Stock was at 01/29/26 03:26 PM ET
What is the market capitalization of Krystal Biotech, Inc. - Common Stock?
The market capitalization of Krystal Biotech, Inc. - Common Stock is 6.22B
How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?
Krystal Biotech, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap